Product NDC: | 0002-4456 |
Proprietary Name: | ZYPREXA |
Non Proprietary Name: | Olanzapine |
Active Ingredient(s): | 20 mg/1 & nbsp; Olanzapine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0002-4456 |
Labeler Name: | Eli Lilly and Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021086 |
Marketing Category: | NDA |
Start Marketing Date: | 20010901 |
Package NDC: | 0002-4456-85 |
Package Description: | 30 DOSE PACK in 1 CARTON (0002-4456-85) > 1 BLISTER PACK in 1 DOSE PACK (0002-4456-01) > 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
NDC Code | 0002-4456-85 |
Proprietary Name | ZYPREXA |
Package Description | 30 DOSE PACK in 1 CARTON (0002-4456-85) > 1 BLISTER PACK in 1 DOSE PACK (0002-4456-01) > 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Product NDC | 0002-4456 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Olanzapine |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20010901 |
Marketing Category Name | NDA |
Labeler Name | Eli Lilly and Company |
Substance Name | OLANZAPINE |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Atypical Antipsychotic [EPC] |